首页 > 最新文献

Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy最新文献

英文 中文
Frequent, perseverant therapy with plasma exchange in Japanese patients with rapidly progressive interstitial lung disease caused by anti-MDA5 antibody-positive dermatomyositis: A report of two cases. 频繁持续血浆置换治疗日本由抗mda5抗体阳性皮肌炎引起的快速进展性间质性肺病患者:两例报告
Tomomi Motohashi, Yukihiro Wada, Yasuo Takeuchi
{"title":"Frequent, perseverant therapy with plasma exchange in Japanese patients with rapidly progressive interstitial lung disease caused by anti-MDA5 antibody-positive dermatomyositis: A report of two cases.","authors":"Tomomi Motohashi, Yukihiro Wada, Yasuo Takeuchi","doi":"10.1111/1744-9987.14258","DOIUrl":"10.1111/1744-9987.14258","url":null,"abstract":"","PeriodicalId":94253,"journal":{"name":"Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy","volume":" ","pages":"914-915"},"PeriodicalIF":1.2,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143191240","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence and Associated Factors of Social Frailty in Older Patients on Maintenance Hemodialysis: A Multi-Centre Cross-Sectional Study. 维持性血液透析老年患者社会衰弱的患病率及相关因素:一项多中心横断面研究
Qin Zhang, Xu-Hua Zhou, Ying Zhu, Lin Chen, Ying-Jun Zhang, Mei Shi

Introduction: Given that social frailty is closely associated with adverse health outcomes among older maintenance hemodialysis (MHD) patients, this study aimed to investigate the prevalence of social frailty among older MHD patients, with an emphasis on its correlation with factors such as family functioning, self-care ability, depression, and physical frailty.

Methods: A multi-center cross-sectional investigation was conducted to recruit older patients with MHD between September and December 2024 from four hemodialysis centers in four tertiary hospitals in Sichuan Province, China. Self-report scales were employed to collect general information and assess the participants' social frailty, family functioning, depression, and physical frailty. Univariate analysis and binary logistic regression analysis were adopted to determine the predictors of social frailty.

Results: A total of 386 older MHD patients were included in the analysis. Of the participants, 205 (53.1%) were diagnosed with social frailty. Binary logistic regression analyses demonstrated that family functioning (OR = 0.863, 95% CI: 0.776-0.960, p = 0.007), self-care ability (OR = 3.527, 95% CI: 1.958-6.352, p < 0.001), depression (OR = 2.007, 95% CI: 1.180-3.415, p = 0.010), and physical frailty (OR = 2.261, 95% CI: 1.237-4.133, p = 0.008) were significantly associated with social frailty among older MHD patients.

Conclusions: Social frailty is highly prevalent among older patients with MHD. In addition, family function, self-care ability, depression, and physical frailty were detected to be independently associated with social frailty. These findings could facilitate the refinement of daily care strategies for older patients with MHD to reduce or mitigate the negative effects of social frailty.

鉴于社会脆弱与老年维持性血液透析(MHD)患者的不良健康结局密切相关,本研究旨在调查老年MHD患者中社会脆弱的患病率,重点研究其与家庭功能、自我照顾能力、抑郁和身体虚弱等因素的相关性。方法:采用多中心横断面调查方法,从四川省四所三级医院的四个血液透析中心招募2024年9月至12月的老年MHD患者。采用自我报告量表收集一般信息,评估参与者的社会脆弱性、家庭功能、抑郁和身体脆弱性。采用单因素分析和二元logistic回归分析确定社会脆弱性的预测因子。结果:386例老年MHD患者被纳入分析。在参与者中,205人(53.1%)被诊断为社会脆弱。二元logistic回归分析显示,家庭功能(OR = 0.863, 95% CI: 0.776 ~ 0.960, p = 0.007)、自我照顾能力(OR = 3.527, 95% CI: 1.958 ~ 6.352, p)、社会脆弱在老年MHD患者中非常普遍。此外,家庭功能、自我照顾能力、抑郁和身体虚弱被发现与社会脆弱独立相关。这些发现有助于改进老年MHD患者的日常护理策略,以减少或减轻社交衰弱的负面影响。
{"title":"Prevalence and Associated Factors of Social Frailty in Older Patients on Maintenance Hemodialysis: A Multi-Centre Cross-Sectional Study.","authors":"Qin Zhang, Xu-Hua Zhou, Ying Zhu, Lin Chen, Ying-Jun Zhang, Mei Shi","doi":"10.1111/1744-9987.70070","DOIUrl":"10.1111/1744-9987.70070","url":null,"abstract":"<p><strong>Introduction: </strong>Given that social frailty is closely associated with adverse health outcomes among older maintenance hemodialysis (MHD) patients, this study aimed to investigate the prevalence of social frailty among older MHD patients, with an emphasis on its correlation with factors such as family functioning, self-care ability, depression, and physical frailty.</p><p><strong>Methods: </strong>A multi-center cross-sectional investigation was conducted to recruit older patients with MHD between September and December 2024 from four hemodialysis centers in four tertiary hospitals in Sichuan Province, China. Self-report scales were employed to collect general information and assess the participants' social frailty, family functioning, depression, and physical frailty. Univariate analysis and binary logistic regression analysis were adopted to determine the predictors of social frailty.</p><p><strong>Results: </strong>A total of 386 older MHD patients were included in the analysis. Of the participants, 205 (53.1%) were diagnosed with social frailty. Binary logistic regression analyses demonstrated that family functioning (OR = 0.863, 95% CI: 0.776-0.960, p = 0.007), self-care ability (OR = 3.527, 95% CI: 1.958-6.352, p < 0.001), depression (OR = 2.007, 95% CI: 1.180-3.415, p = 0.010), and physical frailty (OR = 2.261, 95% CI: 1.237-4.133, p = 0.008) were significantly associated with social frailty among older MHD patients.</p><p><strong>Conclusions: </strong>Social frailty is highly prevalent among older patients with MHD. In addition, family function, self-care ability, depression, and physical frailty were detected to be independently associated with social frailty. These findings could facilitate the refinement of daily care strategies for older patients with MHD to reduce or mitigate the negative effects of social frailty.</p>","PeriodicalId":94253,"journal":{"name":"Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy","volume":" ","pages":"878-884"},"PeriodicalIF":1.2,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144796597","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Examination of the Concordance Between Healthcare Professionals' and the Patient's Own Assessment of the Peritoneal Dialysis Catheter Exit Site. 医护人员与患者对腹膜透析导管出口位置评估的一致性检验。
Junichiro Nakata, Haruna Fukuzaki, Takuya Maeda, Kai Suzuki, Toshiki Kano, Nao Nohara, Hiroaki Io, Yusuke Suzuki

Introduction: Accurate patient self-assessment of catheter exit-site conditions is vital to prevent catheter-related infections (CRI) and ensure effective treatment in patients with peritoneal dialysis (PD). This study aimed to evaluate the concordance between PD patients' self-assessment of their catheter exit-site conditions and that of healthcare professionals and to analyze the trend in concordance.

Methods: A prospective observational study was conducted on 44 patients who started PD. The patients were assessed monthly using an exit-site scoring system. Questionnaires were used for patients' self-assessments. The concordance between both evaluations was analyzed over 12 months.

Results: The mean concordance rate between patient self-assessments and healthcare professional evaluations was 88%. The concordance rate was higher when no abnormalities were detected (93.8%) and lower when abnormalities were detected (63.2%), decreasing over time in both cases.

Conclusions: Overall, a high concordance was observed between patient and healthcare professional assessments of PD catheter exit sites. However, the concordance was lower when abnormalities were present and tended to decrease over time, highlighting the potential need for continuous patient education to maintain accurate self-assessment.

Trial registration: UMIN000037871 and 000039224.

导言:对腹膜透析(PD)患者导管退出部位情况进行准确的患者自我评估对于预防导管相关性感染(CRI)和确保有效治疗至关重要。本研究旨在评估PD患者对导管出口情况的自评与医护人员的自评是否一致,并分析其一致性趋势。方法:对44例PD患者进行前瞻性观察研究。每个月对患者进行评估,采用退出部位评分系统。采用问卷对患者进行自我评估。在12个月内分析两种评价的一致性。结果:患者自我评价与医护人员评价的平均符合率为88%。未检出异常时的符合率较高(93.8%),检出异常时的符合率较低(63.2%),两者的符合率均随时间而降低。结论:总体而言,患者和医疗保健专业人员对PD导管出口位置的评估高度一致。然而,当出现异常时,一致性较低,并随着时间的推移而降低,这突出了对患者进行持续教育以保持准确自我评估的潜在需求。试验注册:UMIN000037871和000039224。
{"title":"Examination of the Concordance Between Healthcare Professionals' and the Patient's Own Assessment of the Peritoneal Dialysis Catheter Exit Site.","authors":"Junichiro Nakata, Haruna Fukuzaki, Takuya Maeda, Kai Suzuki, Toshiki Kano, Nao Nohara, Hiroaki Io, Yusuke Suzuki","doi":"10.1111/1744-9987.70076","DOIUrl":"10.1111/1744-9987.70076","url":null,"abstract":"<p><strong>Introduction: </strong>Accurate patient self-assessment of catheter exit-site conditions is vital to prevent catheter-related infections (CRI) and ensure effective treatment in patients with peritoneal dialysis (PD). This study aimed to evaluate the concordance between PD patients' self-assessment of their catheter exit-site conditions and that of healthcare professionals and to analyze the trend in concordance.</p><p><strong>Methods: </strong>A prospective observational study was conducted on 44 patients who started PD. The patients were assessed monthly using an exit-site scoring system. Questionnaires were used for patients' self-assessments. The concordance between both evaluations was analyzed over 12 months.</p><p><strong>Results: </strong>The mean concordance rate between patient self-assessments and healthcare professional evaluations was 88%. The concordance rate was higher when no abnormalities were detected (93.8%) and lower when abnormalities were detected (63.2%), decreasing over time in both cases.</p><p><strong>Conclusions: </strong>Overall, a high concordance was observed between patient and healthcare professional assessments of PD catheter exit sites. However, the concordance was lower when abnormalities were present and tended to decrease over time, highlighting the potential need for continuous patient education to maintain accurate self-assessment.</p><p><strong>Trial registration: </strong>UMIN000037871 and 000039224.</p>","PeriodicalId":94253,"journal":{"name":"Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy","volume":" ","pages":"898-904"},"PeriodicalIF":1.2,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144984698","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Could Low Altitude Predict the Use of Erythropoietin-Stimulating Agents in Hemodialysis Patients? 低纬度能否预测血液透析患者使用促红细胞生成素?
Emre Yasar, Alper Azak, Sinem Girgin, Gulay Ulusal Okyay, Irem Pembegul

Introduction: Altitude may influence the requirement for erythropoiesis-stimulating agent (ESA) therapy in patients undergoing hemodialysis (HD). This study aimed to compare anemia-related parameters, ESA utilization, and intravenous (IV) iron supplementation among HD patients residing at different altitudes.

Methods: This retrospective-multicenter study was conducted in three provinces of Türkiye, each located at a distinct altitude: Balikesir (139 m; low-altitude-group [LA]), Malatya (964 m; moderate-altitude-group [MA]), and Hakkari (1728 m; high-altitude-group[HA]).

Results: Two hundred and twenty nine HD patients were included in the study: 99 in the LA group, 77 in the MA group, and 53 in the HA group. The mean age was 59 ± 13 years. ESA use was observed in 92 (93%) patients in the LA group, 61 (73%) in the MA group, and 43 (81%) in the HA group (p = 0.021). Age (OR: 1.102, 95% CI: 1.035-1.174, p = 0.003), female gender (OR: 6.068, 95% CI: 1.080-34.111, p = 0.041), residing at LA (OR: 12.845, 95% CI: 1.833-90.118, p = 0.010), IV iron use (OR: 21.015, 95% CI: 3.397-130.009, p = 0.001), hematocrit (OR: 0.364, 95% CI: 0.229-0.578, p < 0.001), and ferritin (OR: 1.003, 95% CI: 1.001-1.005, p = 0.007) were identified as independent predictors of ESA use.

Conclusion: Residing at LA was associated with increased ESA requirements in HD patients, suggesting that altitude may be a relevant factor in anemia management.

简介:海拔可能影响血液透析(HD)患者对促红细胞生成剂(ESA)治疗的需求。本研究旨在比较居住在不同海拔地区的HD患者的贫血相关参数、ESA使用和静脉(IV)补铁。方法:本回顾性多中心研究在斯里兰卡三个不同海拔的省份进行,分别是Balikesir(海拔139 m,低海拔组[LA])、Malatya(海拔964 m,中等海拔组[MA])和Hakkari(海拔1728 m,高海拔组[HA])。结果:共纳入229例HD患者,其中LA组99例,MA组77例,HA组53例。平均年龄59±13岁。LA组92例(93%)患者使用ESA, MA组61例(73%)患者使用ESA, HA组43例(81%)患者使用ESA (p = 0.021)。年龄(OR: 1.102, 95% CI: 1.035-1.174, p = 0.003)、女性(OR: 6.068, 95% CI: 1.080-34.111, p = 0.041)、居住在洛杉矶(OR: 12.845, 95% CI: 1.833-90.118, p = 0.010)、静脉注射铁(OR: 21.015, 95% CI: 3.397-130.009, p = 0.001)、红细胞压积(OR: 0.364, 95% CI: 0.228 -0.578, p)结论:居住在洛杉矶与HD患者ESA需求增加相关,提示海拔可能是贫血管理的一个相关因素。
{"title":"Could Low Altitude Predict the Use of Erythropoietin-Stimulating Agents in Hemodialysis Patients?","authors":"Emre Yasar, Alper Azak, Sinem Girgin, Gulay Ulusal Okyay, Irem Pembegul","doi":"10.1111/1744-9987.70075","DOIUrl":"10.1111/1744-9987.70075","url":null,"abstract":"<p><strong>Introduction: </strong>Altitude may influence the requirement for erythropoiesis-stimulating agent (ESA) therapy in patients undergoing hemodialysis (HD). This study aimed to compare anemia-related parameters, ESA utilization, and intravenous (IV) iron supplementation among HD patients residing at different altitudes.</p><p><strong>Methods: </strong>This retrospective-multicenter study was conducted in three provinces of Türkiye, each located at a distinct altitude: Balikesir (139 m; low-altitude-group [LA]), Malatya (964 m; moderate-altitude-group [MA]), and Hakkari (1728 m; high-altitude-group[HA]).</p><p><strong>Results: </strong>Two hundred and twenty nine HD patients were included in the study: 99 in the LA group, 77 in the MA group, and 53 in the HA group. The mean age was 59 ± 13 years. ESA use was observed in 92 (93%) patients in the LA group, 61 (73%) in the MA group, and 43 (81%) in the HA group (p = 0.021). Age (OR: 1.102, 95% CI: 1.035-1.174, p = 0.003), female gender (OR: 6.068, 95% CI: 1.080-34.111, p = 0.041), residing at LA (OR: 12.845, 95% CI: 1.833-90.118, p = 0.010), IV iron use (OR: 21.015, 95% CI: 3.397-130.009, p = 0.001), hematocrit (OR: 0.364, 95% CI: 0.229-0.578, p < 0.001), and ferritin (OR: 1.003, 95% CI: 1.001-1.005, p = 0.007) were identified as independent predictors of ESA use.</p><p><strong>Conclusion: </strong>Residing at LA was associated with increased ESA requirements in HD patients, suggesting that altitude may be a relevant factor in anemia management.</p>","PeriodicalId":94253,"journal":{"name":"Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy","volume":" ","pages":"890-897"},"PeriodicalIF":1.2,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144984641","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Cardiac Rehabilitation on Cardiovascular Events in Patients With Advanced Chronic Kidney Disease. 心脏康复对晚期慢性肾病患者心血管事件的影响。
Tomoaki Hama, Takatoshi Kakuta, Kazushige Amano, Akiko Ushijima, Fuminobu Yoshimachi, Yuji Ikari

Introduction: Little is known about the effect of cardiac rehabilitation (CR) on cardiovascular events in patients with advanced chronic kidney disease (CKD).

Methods: We performed a retrospective cohort study in 189 patients with an estimated glomerular filtration rate of less than 30 mL/min/1.73 m2 who were referred to our outpatient CR center. They were divided into two groups according to whether they participated in CR or not, and compared for major adverse cardiovascular events (MACEs) incidences.

Results: There were 143 that participated in CR and 46 that did not. The cumulative MACE rates in the participation group were lower than in the non-participation group (48% vs. 61%, p = 0.015). The hazard ratio for all-cardiovascular events in the participation group as compared to the non-participation group after adjusting for confounders was 0.56 (95% CI, 0.35-0.89, p = 0.014).

Conclusion: CR might reduce MACEs in patients with advanced CKD.

导读:关于心脏康复(CR)对晚期慢性肾脏疾病(CKD)患者心血管事件的影响知之甚少。方法:我们对189例估计肾小球滤过率小于30ml /min/1.73 m2的患者进行了回顾性队列研究,这些患者转介到门诊CR中心。根据是否参加CR分为两组,比较主要不良心血管事件(mace)发生率。结果:参加CR 143例,未参加CR 46例。参与组的累积MACE率低于未参与组(48%比61%,p = 0.015)。调整混杂因素后,参与组与未参与组的全心血管事件风险比为0.56 (95% CI, 0.35-0.89, p = 0.014)。结论:CR可降低晚期CKD患者的mace。
{"title":"Effect of Cardiac Rehabilitation on Cardiovascular Events in Patients With Advanced Chronic Kidney Disease.","authors":"Tomoaki Hama, Takatoshi Kakuta, Kazushige Amano, Akiko Ushijima, Fuminobu Yoshimachi, Yuji Ikari","doi":"10.1111/1744-9987.70069","DOIUrl":"10.1111/1744-9987.70069","url":null,"abstract":"<p><strong>Introduction: </strong>Little is known about the effect of cardiac rehabilitation (CR) on cardiovascular events in patients with advanced chronic kidney disease (CKD).</p><p><strong>Methods: </strong>We performed a retrospective cohort study in 189 patients with an estimated glomerular filtration rate of less than 30 mL/min/1.73 m<sup>2</sup> who were referred to our outpatient CR center. They were divided into two groups according to whether they participated in CR or not, and compared for major adverse cardiovascular events (MACEs) incidences.</p><p><strong>Results: </strong>There were 143 that participated in CR and 46 that did not. The cumulative MACE rates in the participation group were lower than in the non-participation group (48% vs. 61%, p = 0.015). The hazard ratio for all-cardiovascular events in the participation group as compared to the non-participation group after adjusting for confounders was 0.56 (95% CI, 0.35-0.89, p = 0.014).</p><p><strong>Conclusion: </strong>CR might reduce MACEs in patients with advanced CKD.</p>","PeriodicalId":94253,"journal":{"name":"Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy","volume":" ","pages":"856-865"},"PeriodicalIF":1.2,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12586301/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144786329","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Commentary on "Association Between Complex Indices of Blood Cell Types and Lipid Levels With All-Cause, Cardiovascular Mortality in Hemodialysis Patients: A Multicenter Retrospective Study". 对“血透患者血细胞类型和血脂水平复杂指标与全因心血管死亡率的关系:一项多中心回顾性研究”的评论。
Sahar Sadr Moharerpour, Mohammad Barary, Soheil Ebrahimpour
{"title":"Commentary on \"Association Between Complex Indices of Blood Cell Types and Lipid Levels With All-Cause, Cardiovascular Mortality in Hemodialysis Patients: A Multicenter Retrospective Study\".","authors":"Sahar Sadr Moharerpour, Mohammad Barary, Soheil Ebrahimpour","doi":"10.1111/1744-9987.70051","DOIUrl":"10.1111/1744-9987.70051","url":null,"abstract":"","PeriodicalId":94253,"journal":{"name":"Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy","volume":" ","pages":"931-932"},"PeriodicalIF":1.2,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144236383","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dialysis Disequilibrium Syndrome Showing Reversible Cerebral Edema in a Maintenance Hemodialysis Patient. 维持性血液透析患者出现可逆性脑水肿的透析不平衡综合征。
Reona Hoshino, Hiroo Kasahara, Yoshio Ikeda
{"title":"Dialysis Disequilibrium Syndrome Showing Reversible Cerebral Edema in a Maintenance Hemodialysis Patient.","authors":"Reona Hoshino, Hiroo Kasahara, Yoshio Ikeda","doi":"10.1111/1744-9987.70041","DOIUrl":"10.1111/1744-9987.70041","url":null,"abstract":"","PeriodicalId":94253,"journal":{"name":"Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy","volume":" ","pages":"920-921"},"PeriodicalIF":1.2,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144060209","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigation of Changes in the Rate of Renal Function Decline Before and After Embedding Peritoneal Dialysis Catheter. 埋置腹膜透析导管前后肾功能下降率变化的研究。
Kento Fukumitsu, Kiichiro Fujisaki, Hidenobu Koga, Toshiaki Nakano
{"title":"Investigation of Changes in the Rate of Renal Function Decline Before and After Embedding Peritoneal Dialysis Catheter.","authors":"Kento Fukumitsu, Kiichiro Fujisaki, Hidenobu Koga, Toshiaki Nakano","doi":"10.1111/1744-9987.70049","DOIUrl":"10.1111/1744-9987.70049","url":null,"abstract":"","PeriodicalId":94253,"journal":{"name":"Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy","volume":" ","pages":"927-928"},"PeriodicalIF":1.2,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144176258","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Smart, Individualized Green Hemodiafiltration - Effects of Individualized Dialysate Flow Through AutoFlow on Dialysate Consumption and Parameters of Dialysis Adequacy in the Setting of Online Hemodiafiltration. 智能、个性化的绿色血液滤过——在在线血液滤过设置中,通过AutoFlow进行个性化透析对透析消耗和透析充分性参数的影响。
Vanessa David, Bastian Au, Torsten M Meyer, Kijanosh Lehmann, Jan T Kielstein

Introduction: High-dose online HDF compared with hemodialysis reduces all-cause mortality, but increases water consumption. We postulate that the conundrum could be solved by individualizing dialysate flow.

Methods: Thirty CKD5D patients undergoing online HDF post-dilution were changed from fixed dialysate flow (500 mL/min) to individualized dialysate flow, resulting in a dialysate flow that was always 20% higher than the blood flow. Kt/V urea, K+, Phos, and pill burden in one quater pre as well as four quarters after the change were evaluated.

Results: The practice change resulted in a reduction of the fixed dialysate flow from 500 to 360 (240-383) mL/min. Parameters of dialysis adequacy did not change; neither did the medication.

Conclusion: An individualization of the dialysate flow saved about 36 L dialysate per session; hence, even in light of 23 L used for online HDF, the net burden on the environment could be reduced. Neither dialysis adequacy nor pill burden was negatively affected.

与血液透析相比,高剂量在线HDF降低了全因死亡率,但增加了用水量。我们假设这个难题可以通过个性化透析液流动来解决。方法:30例CKD5D患者进行在线HDF后稀释,将固定透析液流量(500 mL/min)改为个体化透析液流量,使透析液流量始终高于血流量20%。分别对改变前后4个季度的Kt/Vurea、K+、Phos和药片负荷进行了评估。结果:实践改变导致固定透析液流量从500减少到360 (240-383)mL/min。透析充分性参数无变化;药物也没有。结论:透析流量的个体化每次可节省约36l透析液;因此,即使在线HDF使用23 L,对环境的净负担也可以减少。透析充分性和药物负担均未受到负面影响。
{"title":"Smart, Individualized Green Hemodiafiltration - Effects of Individualized Dialysate Flow Through AutoFlow on Dialysate Consumption and Parameters of Dialysis Adequacy in the Setting of Online Hemodiafiltration.","authors":"Vanessa David, Bastian Au, Torsten M Meyer, Kijanosh Lehmann, Jan T Kielstein","doi":"10.1111/1744-9987.70072","DOIUrl":"10.1111/1744-9987.70072","url":null,"abstract":"<p><strong>Introduction: </strong>High-dose online HDF compared with hemodialysis reduces all-cause mortality, but increases water consumption. We postulate that the conundrum could be solved by individualizing dialysate flow.</p><p><strong>Methods: </strong>Thirty CKD5D patients undergoing online HDF post-dilution were changed from fixed dialysate flow (500 mL/min) to individualized dialysate flow, resulting in a dialysate flow that was always 20% higher than the blood flow. Kt/V <sub>urea</sub>, K<sup>+</sup>, Phos, and pill burden in one quater pre as well as four quarters after the change were evaluated.</p><p><strong>Results: </strong>The practice change resulted in a reduction of the fixed dialysate flow from 500 to 360 (240-383) mL/min. Parameters of dialysis adequacy did not change; neither did the medication.</p><p><strong>Conclusion: </strong>An individualization of the dialysate flow saved about 36 L dialysate per session; hence, even in light of 23 L used for online HDF, the net burden on the environment could be reduced. Neither dialysis adequacy nor pill burden was negatively affected.</p>","PeriodicalId":94253,"journal":{"name":"Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy","volume":" ","pages":"885-889"},"PeriodicalIF":1.2,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144823496","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Continuous Kidney Replacement Therapy and Outcomes of Severe Coronavirus Disease 2019 Treated With Extracorporeal Membrane Oxygenation. 体外膜氧合治疗2019年重症冠状病毒病的持续肾脏替代治疗和疗效
Yoshito Izutani, Yasumasa Kawano, Akihiro Fujita, Shinichi Morimoto, Kentaro Muranishi, Kota Hoshino, Junichi Maruyama, Maiko Nakashio, Junta Noake, Hiroki Hatomoto, Shintaro Yamasaki, Kazuya Yamauchi, Jun Hamaguchi, Naofumi Bunya, Ryuichi Nakayama, Keiki Shimizu, Yoshihiko Nakamura

Introduction: Although continuous kidney replacement therapy (CKRT) for acute kidney injury (AKI) management is common, its effect on the outcomes of patients treated with extracorporeal membrane oxygenation (ECMO) for severe coronavirus disease 2019 (COVID-19) remains unclear. Therefore, we aimed to investigate the impact of CKRT on the outcomes of these patients.

Methods: Using a database of patients with severe COVID-19 who required venovenous ECMO across three centers in Japan, we assessed demographics, clinical parameters, and in-hospital mortality rates from January 2020 to December 2021.

Results: Data of 122 patients treated with ECMO for COVID-19 were analyzed. Forty-five patients required CKRT; the in-hospital mortality rate was 28.7%. Multivariate analysis showed age and CKRT were independent risk factors for in-hospital mortality. The in-hospital mortality rate was significantly higher in the CKRT group.

Conclusion: CKRT was associated with significantly high in-hospital mortality in patients treated with ECMO for severe COVID-19.

导论:尽管持续肾脏替代疗法(CKRT)在急性肾损伤(AKI)治疗中很常见,但其对接受体外膜氧合(ECMO)治疗2019年严重冠状病毒病(COVID-19)患者预后的影响尚不清楚。因此,我们旨在研究CKRT对这些患者预后的影响。方法:使用日本三个中心需要静脉静脉ECMO的重症COVID-19患者数据库,评估2020年1月至2021年12月的人口统计学、临床参数和住院死亡率。结果:对122例新冠肺炎ECMO患者的资料进行分析。45例患者需要CKRT;住院死亡率为28.7%。多因素分析显示,年龄和CKRT是院内死亡的独立危险因素。CKRT组的住院死亡率明显更高。结论:CKRT与重症COVID-19患者接受ECMO治疗的住院死亡率显著升高相关。
{"title":"Continuous Kidney Replacement Therapy and Outcomes of Severe Coronavirus Disease 2019 Treated With Extracorporeal Membrane Oxygenation.","authors":"Yoshito Izutani, Yasumasa Kawano, Akihiro Fujita, Shinichi Morimoto, Kentaro Muranishi, Kota Hoshino, Junichi Maruyama, Maiko Nakashio, Junta Noake, Hiroki Hatomoto, Shintaro Yamasaki, Kazuya Yamauchi, Jun Hamaguchi, Naofumi Bunya, Ryuichi Nakayama, Keiki Shimizu, Yoshihiko Nakamura","doi":"10.1111/1744-9987.70071","DOIUrl":"10.1111/1744-9987.70071","url":null,"abstract":"<p><strong>Introduction: </strong>Although continuous kidney replacement therapy (CKRT) for acute kidney injury (AKI) management is common, its effect on the outcomes of patients treated with extracorporeal membrane oxygenation (ECMO) for severe coronavirus disease 2019 (COVID-19) remains unclear. Therefore, we aimed to investigate the impact of CKRT on the outcomes of these patients.</p><p><strong>Methods: </strong>Using a database of patients with severe COVID-19 who required venovenous ECMO across three centers in Japan, we assessed demographics, clinical parameters, and in-hospital mortality rates from January 2020 to December 2021.</p><p><strong>Results: </strong>Data of 122 patients treated with ECMO for COVID-19 were analyzed. Forty-five patients required CKRT; the in-hospital mortality rate was 28.7%. Multivariate analysis showed age and CKRT were independent risk factors for in-hospital mortality. The in-hospital mortality rate was significantly higher in the CKRT group.</p><p><strong>Conclusion: </strong>CKRT was associated with significantly high in-hospital mortality in patients treated with ECMO for severe COVID-19.</p>","PeriodicalId":94253,"journal":{"name":"Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy","volume":" ","pages":"866-870"},"PeriodicalIF":1.2,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144786328","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1